Clinical Trial Results: Prognostic Impact of the Neutrophil/Lymphocyte Ratio (NLR) in the Treatment of First-line Metastatic or Locally Advanced Breast Cancer Treated With CDK4/6 Inhibitor. [NA]

View source ↗

Summary

Clinical trial results examining the prognostic impact of the neutrophil/lymphocyte ratio in first-line metastatic or locally advanced breast cancer treated wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Breast Cancer, Metastatic Breast Cancer | NA | Status: COMPLETED | Results posted: 2026-06-11